Glycosaminoglycans were extracted from bovine liver capsule with 4M-guanidinium chloride, resulting in solubilization of approx. 90% of the total uronic acid-containing polysaccharide of the tissue. The extracted polysaccharide was purified and fractionated by anion-exchange chromatography on DEAE-cellulose, density-gradient ultracentrifugation in CsCl and finally gel chromatography on Sepharose 4B. By using these procedures, the two major polysaccharide components, dermatan sulphate and heparin, which constituted 55 and 30 % respectively of the total glycosaminoglycan content of the tissue, were separated from each other. Analysis of the macromolecular properties of the two polysaccharides showed that heparin existed exclusively as single polysaccharide chains, whereas dermatan sulphate occurred largely as a proteoglycan (protein content, 74% dry wt.). The purified heparin preparation was subjected to sedimentationequilibrium ultracentrifugation, indicating a molecular weight of 8800. Analysis for neutral sugars (by g.l.c.) showed 0.1 residue of xylose and 0.2 residue of galactose/ polysaccharide chain; serine amounted to 0.3 residue/polysaccharide chain. Reduction of the heparin with NaB3H4 resulted in incorporation of 3H, approximately corresponding to one reducible group/polysaccharide chain. The 3H-labelled sugar residue was liberated by a combination of acid hydrolysis and deaminative cleavage of the polysaccharide with HNO2; it was subsequently identified as an aldonic acid by paper electrophoresis. Most of the heparin chains thus contained a uronic acid residue in reducing position. It is suggested that heparin isolated from bovine liver capsule is a degradation product released from larger molecules by an endo-glycuronidase.
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Most of the glycosaminoglycans in connective tissue occur as proteoglycans, consisting of several polysaccharide chains covalently bound to a common polypeptide (Lindahl & Roden, 1972) . The carbohydrate components of such proteoglycans have been identified as chondroitin 4-sulphate, chondroitin 6-sulphate, keratan sulphate and dermatan sulphate; also there is evidence to indicate that heparan sulphate may exist in the native state as a similar macromolecule (Jansson & Lindahl, 1970; Kraemer & Smith, 1974; A. Hallen & L. Jansson, unpublished work) .
Structural studies on commercially available heparin preparations showed the presence of the polysaccharide-protein linkageregion, typical ofmost proteoglycans (Lindahl & Roden, 1972) , involving a galactosyl-galactosyl-xylose trisaccharide sequence linked to a serine residue. The occurrence of heparin proteoglycans, suggested by this finding, was reported by Serafini-Fracassini et al. (1969) and by Lloyd et al. (1967a,b) .
Attempts in our laboratory to isolate a native heparin proteoglycan from bovine liver capsule Vol. 145 yielded single polysaccharide chains and polysaccharide-peptides only, accounting for about 40 % of the total heparin content of the tissue (Lindahl, 1970) . It was suggested that part of the isolated material had been subjected to degradation by an endopolysaccharidase. This conclusion was disputed by Serafini-Fracassini et al. (1973) , who claimed that heparin isolated from bovine liver capsule contained one residue of xylose/polysaccharide chain, and further that a major fraction of the polysaccharide preparation occurred as doublet molecules, consisting of two heparin chains linked to a common polypeptide. Because of these conflicting findings we reinvestigated the problem.
In the present study heparin was isolated from bovine liver capsule by the use of mild but efficient extraction procedures; the yield exceeded 80% of the total heparin content of the tissue. The macromolecular properties of the isolated polysaccharide conformed in all respects to our previous findings (Lindahl, 1970) , thus demonstrating that practically all of the heparin in bovine liver capsule occurs as single polysaccharide chains. Further, most of these molecules were shown to lack the polysaccharide-protein linkage region, instead having a reducible, terminal uronic acid residue. It is therefore proposed that a major portion of the livercapsule heparin is a degradation product released from a larger molecule by an endo-glycuronidase.
Experimental

Materials
Bovine liver capsules (i.e. the fibrous connective tissue capsule also denoted Glisson's capsule) were removed from the livers within 30min after deatb of the animals, and were carefully freed of liver tissue. Capsules were homogenized by repeated passage through a bacteria press at -20'C (Edebo, 1960) and were then defatted with acetone-ether (Blix, 1941) .
Heparin (stage 14; prepared from pig intestinal mucosa) was purchased from Wilson Laboratories, Chicago, Ill., U.S.A., and was purified by repeated precipitation with cetylpyridinium chloride from 1.2M-NaCl, essentially as described by Lindahl et al. (1965) . Samples of dermatan sulphate, chondroitin sulphate and hyaluronic acid were kindly supplied by Dr. A. Wasteson of this Institute.
Papain was crystallized from a crude preparation (typeII; Sigma Chemical Co., St. Louis, Mo., U.S.A.) by the procedure of Kimmel & Smith (1954) , and was used as a suspension containing approx. 26mg of protein/ml. L-Gulono-b-lactone was a product of Fluka AG, Buchs S.G., Switzerland. D-Glucuronic acid was purchased from Sigma Chemical Co.
[14C]Glucuronosyl-anhydromannitol was isolated as described by Lindahl et al. (1973) from labelled, non-sulphated polysaccharide synthesized with a mastocytoma microsomal fraction. [U-'4C]Glucose (360mCi/ mmol) and NaB3H4 (6.3Ci/mmol) were purchased from The Radiochemical Centre, Amersham, Bucks., U.K. Stock solutions of labelled NaB3H4 were prepared by dissolving portions (l00mCi) in 0.1 ml of 0.1 M-NaOH (Koeltzow et al., 1968) . DEAE-cellulose anion exchanger, Whatman type DE-22, was purchased from W. and R. Balston Ltd., Maidstone, Kent, U.K., and was pretreated according to the manufacturer's instructions before use. Sepharose 4B and Sephadex G-100 were obtained from Pharmacia Fine Chemicals, Uppsala, Sweden. Guanidinium chloride was obtained from Fluka AG, and was purified by treatment with activated charcoal [15% (w/v) suspension in saturated guanidinium chloride]. The charcoal was removed by filtration.
Methods
Analytical methods. Uronic acid was determined as described by Bitter & Muir (1962) . Glucosamine/ galactosamine ratios were determined by rapid highpressure ion-exchange chromatography of the amino sugar monosaccharides on Aminex A 5 (Bio-Rad Laboratories, Richmond, California) as described by Lohmander (1972) ; polysaccharides were prepared for analysis by hydrolysis in 4M-HCI at 100°C for 14h. Glucosamine residues with Nsulphated (or unsubstituted) amino groups were determined quantitatively by the indole reaction, after conversion into anhydromannose units by treatment with HNO2 under conditions of reaction A as described by Lindahl et al. (1973) . Amino acid analyses were performed with a Bio-Cal model BC-200 amino acid analyser, after hydrolysis of samples in vacuo with 6M-HCI at 1 10°C for 24h.
Neutral sugars were determined as alditol acetates by g.l.c. Hydrolysis of polysaccharides and conversion of the resulting monosaccharides into the corresponding reduced and acetylated derivatives were done as described previously (Lindahl, 1970) . Samples (1-2p1) were separated at 170°C in a Perkin-Elmer model F30 gas chromatograph, on glass columns (1 .80m x 2mm internal diameter) packed with 3 % (w/w) ECNSS-M on Gas Chrom Q (100-120mesh) (Sawardeker et al., 1965) . N2 was used as carrier gas at a flow rate ofapprox. 30ml/min. Peak areas were measured by planimetry. Electrophoresis of glycosaminoglycans was carried out on strips of cellulose acetate, in 0.1 M-barium acetate, pH6.6 (2.7V/cm for 6h) (Wessler, 1968) or in 0.1 M-HCI, pH 1.2 (1.9V/cm for 2h) (Wessler, 1971 ). The electrophoretic mobility in barium acetate depends primarily on the structure of the polysaccharide backbone, whereas variations in sulphate content are of less importance. In dilute HCI the carboxyl groups of glycosaminoglycuronans are undissociated; the migration rate of polysaccharide in this medium therefore depends exclusively on its degree of sulphation. The combined application of the two methods thus permits the identification of individual glycosaminoglycan components in a polysaccharide mixture. Before electrophoresis, proteoglycans were converted into the single-chain state by treatment with 0.5M-NaOH at 4°C for 20h, followed by neutralization and dialysis.
Gel chromatography of glycosaminoglycans was carried out at 40C, on columns of Sepharose 4B (lcmx95cm) or Sephadex G-100 (1.2cmx90cm). Samples were usually eluted with 1M-NaCl-0.05M-Tris-HCI, pH7.4 (although samples of 3H-labelled heparin were eluted with the same buffer at pH 8.0), at a rate of about 4ml/h.
Paper electrophoresis was done with Whatman 3MM paper, at 70V/cm, in 0.08M-pyridine-0.046M-acetic acid, pH5.3, or in 0.06M-pyridine-0.43M-acetic acid, pH 3.9. Before electrophoresis lactones of aldonic acids were converted into the free acid form by treatment of the samples with aq. 0.25M-NH3 for 1 h at room temperature. Paper chromatography was 1975 performed with Whatman 3MM papers in ethyl acetate-acetic acid-formic acid-water (18:3:1:4, by vol.). Non-radioactive sugars were stained by a silver-dip procedure (Smith, 1960) , whereas 14C-labelled components were located with a Packard model 7201 strip scanner. 3H-labelled components were determined after cutting the paper strips into 1cm pieces, which were transferred to scintillation vials containing 1 ml of water. About 1 h later, lOml of Instagel (Packard Instrument Co., Downers Grove, Ill., U.S.A.) was added; the vials were shaken vigorously and were then counted for radioactivity in either a Packard Tri-Carb 2002 or a Beckman LS 250 liquid-scintillation spectrometer. The counting efficiency for 3H (usually 20-25 %) was determined by using HI20 as internal standard.
Molecular weights of glycosaminoglycans were determined by meniscus-depletion equilibrium ultracentrifugation as described by Chervenka (1970) , at a polysaccharide concentration of 2mg/ml of 1 MNaCl-0.08M-Tris-HCI, pH 7.4. A 12mm40 capillarytype, synthetic-boundary, double-sector cell was used at 200C. Hoparin and dermatan sulphate fractions were centrifuged for 19h and for 21 h at 36000 and 22000rev./min respectively. The values for partial specific volumes used were 0.47ml/g for heparin (Lasker & Stivala, 1966) and 0.54ml/g for dermatan sulphate (Luscombe & Phelps, 1967 The total content of glycosaminoglycuronan in the tissue was determined as follows. Homogenized, defatted, dried liver capsule (2.0g) was suspended in 20ml of 0.05M-sodium acetate buffer, pH5.5, containing 0.3 M-NaCl, 0.01 M-EDTA and 0.01 Mcysteine-HCl. After the addition of 0.5 ml of papain suspension, digestion was allowed to proceed at 65°C for 20h. The liberated polysaccharide was isolated by precipitation with cetylpyridinium chloride from 0.3M-NaCl. After conversion into the sodium form (Lindahl, 1970) , the polysaccharide was quantified by the carbazole reaction.
Results
Fractionation and identification ofglycosaminoglycans
The total glycosaminoglycan content of the liver capsule tissue, determined as uronic acid-containing material precipitable with cetylpyridinium chloride from 0.3M-NaCI, corresponded to 0.81 mg of uronic acid/g of dry tissue. This value may be somewhat too low, owing to incomplete recovery of hyaluronic acid; however, calculations described in the legend to Fig. 3 indicate that this polysaccharide amounted to at most 10% of the total glycosaminoglycan content of the tissue. By extraction with 4M-guanidinium chloride, polysaccharide corresponding to 0.77mg of uronic acid/g of dry tissue (94 % of the total uronic acid) was brought into solution. It may be concluded that at least 80 %, and probably more, of the heparin present in the liver capsule was recovered in the extract.
The extracted polysaccharide was fractionated by anion-exchange chromatography on DEAE-cellulose. Approximately two-thirds of the uronic acid-containing material applied to the column was eluted with 0.5M-NaCl, the remainder being recovered in a 2M-NaCl eluate. Electrophoretic analysis of the 0.5M-NaCl and 2M-NaCl eluates showed dermatan sulphate and heparin respectively as the predominant polysaccharide components (Fig. 1) . In addition, both fractions contained trace amounts of chondroitin sulphate and hyaluronic acid.
Further fractionation of the 0.5M-and 2M-NaCl eluate fractions was achieved by density-gradient centrifugation in CsCl. The uronic acid-containing material in the 0.5M-NaCl eluate was distributed over the entire gradient, with a peak between densities 1.40-1.50g/ml (Fig. 2a) , whereas the Vol. 145 material in the 2M-NaCl eluate appeared preferentially in fractions of higher density (Fig. 2b) . In both separations, contaminating protein or glycoprotein was accumulated in the fractions of lowest density. Gradient fractions were pooled to yield a 'light' and a 'heavy' fraction from each of the 0.5M-NaCl and the 2M-NaCl eluates, as shown in Fig. 2 . In the following, the resulting preparations will be designated as 0.5M-heavy, 0.5M-light, 2M-heavy and 2M-light respectively. The distribution of uronic acidcontaining material between these fractions is given in Scheme 1.
The fractions obtained by density-gradient centrifugation were separated further by gel chromatography on Sepharose 4B (Figs. 3 and 4) . Effluent fractions were combined as indicated in the Figures, and were then analysed for glucosamine/galactosamine ratio and for polysaccharide composition (as determined by cellulose acetate electrophoresis). The 0.5M-heavy and 0.5M-light fractions were both heterogeneous, and showed dermatan sulphate within a wide range of molecular size (Fig. 3) . The major portion of the dermatan sulphate occurred in the 0.5M-light fraction, and appeared as a fairly distinct peak with Ka,. approx. 0.5. The 2M-heavy and 2M-light fractions gave almost identical elution patterns (Fig. 4) , with a single, distinct, retarded peak (Ka,. about 0.9). Heparin was the only polysaccharide detectable on cellulose acetate electrophoresis of the retarded material. In agreement with this finding, glucosamine was the only amino sugar present in significant amounts; further, about 80% of the glucosamine residues were N-sulphated (as indicated by the amounts of anhydromannose determined after deamination of the polysaccharide, related to the uronic acid content of the intact polysaccharide; no corrections were applied for the anomalous high colour yields of the indole and the carbazole reactions respectively).
Calculations based on the quantitative data given in Scheme 1 and in Figs. 3 and 4 indicate that heparin and dermatan sulphate constituted about 30% and 55 % respectively of the total glycosaminoglycans of the liver capsules. The high-molecular-weight portion of the 0.5M-light fraction (dermatan sulphate; see Fig. 3b ) and a low-molecular-weight portion of the 2M-heavy fraction (heparin; see Fig. 4a ) were dialysed, freeze-dried and retained for further analysis.
Macromolecular properties of heparin and dermatan sulphate fractions
Digestion of the isolated dermatan sulphate with papain resulted in considerable degradation, as shown by gel chromatography (Fig. 5) material; see Fig. 5 ) was estimated by ultracentrifugation (Fig. 6b) to be 19 800. In contrast the heparin frac.
tion retained the same mnolecular size during treatment with either papain or alkali (0.5M-NaOH at 40C for 20h). The molecular weight of the combined heparin peak fractions (soe Fig. 4a ) was 8800 (Fig. 6a) (Fig.7) ,was even lower, about one residue for every eight polysaccharide molecules. A similar low xylose content (0.18residue/polysaccharide chain) was determined in the 2 M-light heparin fraction.
The dermatan sulphate preparation (high-molecular-weight portion of0.5M-light fraction) contained large amounts of protein, accounting for about threequarters of the dry weight of the material (Table 1) , Also the xylose content (determined on papaindigested polysaccharide) was higher than that of the heparin fractions, corresponding to about one residue per dermatan sulphate chain.
According to the current concept of heparin and dermatan sulphate structures, the linkage between polysaccharide and polypeptide is mediated exclusively by the galactosyl-galactosyl-xylosyl-serine sequence (Lindahl & Roden, 1972) proteoglycan structure should thus display one xylose residue for each constituent polysaccharide chain, as found for the dermatan sulphate fraction. The relative lack of xylose in the heparin fractions therefore strongly indicates that the majority of these molecules were fragments derived from larger compounds, by cleavage within polysaccharide chains and not by proteolytic scission of a polypeptide core. Further, it may be inferred from the serine/heparin and xylose/heparin molar ratios, that only a minor fraction of the serine residues Vol. 145 could be directly bound to xylose; the presence on these xylose units of peptides rather than single amino acid substituents thus appears likely. These conclusions are in excellent agreement with our previous characterization of heparin, obtained from bovine liver capsule by a different, and less efficient, isolation procedure (Lindahl, 1970 Vol. of effluent (ml) Fig. 5 . Gel chromatography on Sepharose 4B of dermatan sulphate, before (0) and after (0) digestion with papain The analysed material was the high-molecular-weight portion of the 0.5 M-light fraction (see Fig. 3b ). The fractions of the papain-digested material indicated by the horizontal bracket were pooled and subjected to further analysis. For further details see the text.
sugar residue. The presence of such residues was demonstrated by reduction of liver-capsule heparin with NaB3H4. The amount of 3H incorporated was related to the molecular weight of the heparin, yielding a specific radioactivity of 22mCi/mmol of polysaccharide, or 1.3 reducible groups per polysaccharide chain (based on a specific radioactivity for the NaB3H4 used of 68mCi/ mmol, calculated from the 3H/14C ratio of the sorbitol internal standard). This latter value should be regarded as approximate, as several of the parameters involved in the calculations may have been subject to experimental error. The 3H-labelled monosaccharide residue was identified after degradation of the reduced polysaccharide by a combination of acid hydrolysis and deaminative cleavage with HNO2 (see the Experimental section). The products (recovery of radioactivity from labelled heparin, 80%) were analysed by paper electrophoresis at pH5.3 (Fig. 8a) , showing a major component migrating like D-glucuronic acid, L-iduronic acid or L-gulonic acid (which all show the same migration rate under these conditions). On electrophoresis at the lower pH3.9 (Fig. 8b) the charged, labelled component was retarded in relation to the uronic acids, and migrated similarly to the L-gulonic acid standard. These results suggest that the labelled sugar residue was an aldonic acid; owing to lack of material it was not possible to identify this component further.
An aldonic acid (L-gulonic acid or L-idonic acid) would be the expected reduction product of a terminal uronic acid (D-glucuronic acid or L-iduronic acid respectively) residue. Results of model experiments to be reported elsewhere Ogren & Lindahl, 1975) demonstrated that a glucuronic acid residue in the reducible terminal position of a polysaccharide chain was in fact recovered as [3H] gulonic acid by the procedure employed. Glucosamine residues in a similar position were largely converted into an uncharged, labelled deamination product; a smaller fraction appeared as a component instead having terminal, reducible uronic acid residues. These results confirm and extend our previous findings (Lindahl, 1970) , and are clearly at variance with the reports of Serafini-Fracassini et al. (1969 , who claimed that most of the heparin in bovine liver capsule occurs as a macromolecular complex, consisting of two polysaccharide chains joined by a polypeptide. In consequence with these claims, it was stated that all heparin chains contained covalently bound xylose and galactose, and further, that the relative lack of xylose reported in our previous study (Lindahl, 1970) must reflect degradation occurring during isolation. Such degradation appears highly improbable, in view of the following facts. (a) The isolation procedure employed in the present investigation has been extensively, and successfully, applied to the isolation of intact proteoglycans from several types of tissues (Antonopoulos et al., 1974) ; although this procedure differs considerably from that used in our previous study (Lindahl, 1970) , similar low xylose, galactose and serine contents were recorded for the isolated heparin products, irrespective of the preparation procedure used. migrating like the charged disaccharide, glucuronosyl-anhydromannitol. As seen from Fig. 8(a dermatan sulphate contained one residue of xylose per molecule, in contradiction of the possibility that polysaccharide-bound xylose would be selectively lost as a result of the isolation conditions. Degradation does not occur during isolation and therefore the most reasonable explanation for the lack of polysaccharide-protein linkage region in the liver-capsule heparin would seem to be degradation of the polysaccharide in vivo. The resulting fragments were shown to contain uronic acid residues in reducing, terminal position: hence, the enzyme responsible for the degradation should be an endo-glycuronidase. This conclusion is of interest in relation to previous studies on the metabolism of heparin in rodents. Heparin isolated from rat skin occurs as a complex, branched macromolecule, composed of several glycosaminoglycan chains joined by a polysaccharide core (Homer, 1971) . Newly synthesized heparin from neoplastic mouse mast cells displays similar macromolecular properties (Ogren & Lindahl, 1971 ). These macromolecular heparins may be depolymerized by endoglycosidases from various rodent (Ogren & Lindahl, 1971; Homer, 1972; S. Ogren & U. Lindahl, unpublished work) and human (S. Ogren, unpublished work) tissues, yielding fragments similar in size to commercial heparin. In the mouse mastocytoma, biosynthesis and degradation of the macromolecular heparin occur in rapid succession (Ogren & Lindahl, 1971 ; S. Ogren & U. Lindahl, unpublished work); it has been suggested by Homer (1972) that the degradation process may be required to convert the heparin into its physiologically active form. The enzyme responsible for the degradation ofmacromolecular heparin in mouse mastocytoma has been isolated and tentatively identified as an endoglucuronidase (Ogren & Lindahl, 1975) . These findings, in conjunction with the results of the present study, suggest that formation and degradation of macromolecular heparin may occur also in mammals other than rodents (see also Homer, 1970) .
